Cagrilintide 5mg + Semaglutide 5mg – Weight Loss Peptide

What Is the Cagrilintide + Semaglutide Stack?

The Cagrilintide 5mg + Semaglutide 5mg stack is a weight loss peptide combination designed for advanced metabolic research. It brings together two powerful peptides that work through completely different pathways in the body: semaglutide, a well-established GLP-1 receptor agonist, and cagrilintide, a long-acting amylin analogue. Each vial in this research stack contains both peptides at equal 5mg concentrations, allowing researchers to study their combined effects within a single, convenient research format.

This combination has generated significant scientific interest because the two peptides target appetite and metabolism from complementary angles. Semaglutide works through the GLP-1 pathway to reduce hunger, slow stomach emptying, and improve blood sugar control. Cagrilintide works through the amylin pathway to enhance feelings of fullness, further slow digestion, and regulate post-meal glucose levels. Together, they create a broader, more comprehensive effect on weight regulation than either peptide alone.

At RECHEMCO, we supply the Cagrilintide + Semaglutide stack as a research-grade lyophilised powder (freeze-dried) with a purity of 99% or higher for each component. Each box contains 10 vials of the combined product, ensuring a consistent, reliable supply for your laboratory’s metabolic research programmes.

How Does the Cagrilintide + Semaglutide Stack Work? (In Simple Terms)

This stack works by activating two separate hormonal systems that naturally regulate appetite, digestion, and metabolism. Understanding each one helps explain why the combination is so effective.

Semaglutide — The GLP-1 Pathway

Semaglutide mimics GLP-1 (glucagon-like peptide-1), a natural hormone released by the gut after eating. When semaglutide activates GLP-1 receptors, it:

• Tells the pancreas to release insulin when blood sugar is high, keeping glucose levels stable
• Reduces glucagon, a hormone that normally raises blood sugar
• Slows the rate at which food leaves your stomach, extending the feeling of fullness
• Acts directly on appetite centres in the brain, reducing hunger and food cravings
• Works for an entire week from a single administration due to its engineered resistance to enzymatic breakdown

Cagrilintide — The Amylin Pathway

Cagrilintide mimics amylin, a natural hormone released by the pancreas alongside insulin after meals. When cagrilintide activates amylin receptors, it:

• Sends powerful “I’m full” signals to the brain, reducing the desire to eat
• Slows stomach emptying even further, keeping you satisfied for longer
• Helps prevent sharp blood sugar spikes after eating
• Works through receptors in the brainstem that are completely separate from the GLP-1 system

The Synergy — Why the Combination Matters

When semaglutide and cagrilintide are combined, they create a synergistic effect that is greater than the sum of their individual actions. Here’s why:

• Two different appetite pathways are activated at the same time. GLP-1 and amylin receptors are located in different brain regions, meaning the “stop eating” signal comes from multiple directions simultaneously.
• Stomach emptying is slowed through two separate mechanisms, producing a more pronounced and sustained feeling of fullness after meals.
• The risk of the body adapting to one pathway is reduced because two independent systems are being targeted.
• Lower amounts of each peptide may be needed to achieve the same or better results compared to using either one alone at higher amounts.

This dual-pathway approach represents a more sophisticated strategy for weight loss research, and it is why the Cagrilintide + Semaglutide stack is one of the most sought-after combinations in metabolic science today.

Why Is the Cagrilintide + Semaglutide Stack Called a “Weight Loss Peptide” Combination?

In clinical research settings, the combination of cagrilintide and semaglutide has produced remarkable results. In phase 2 clinical trials, this exact combination (at various dose ratios) led to significantly greater weight loss than semaglutide alone. Participants receiving the combination lost substantially more body weight, with results that approached what was previously only achievable through more aggressive interventions.

The weight loss happens because this stack:

• Produces a powerful and sustained reduction in hunger from two separate signalling systems
• Creates a prolonged feeling of fullness after eating smaller meals
• Dramatically slows stomach emptying, making meals more satisfying
• Regulates blood sugar through two complementary mechanisms
• May help reduce cravings for high-calorie and fatty foods
• Provides a more complete appetite control system than single-pathway approaches

For researchers, this combination offers a unique opportunity to study how dual-pathway appetite regulation affects body weight, food intake, metabolic health, and related outcomes in ways that single-peptide studies cannot capture.

What You Will Receive When You Buy Cagrilintide + Semaglutide from RECHEMCO

• One box containing research-grade Cagrilintide + Semaglutide combination
• 10 vials per box — each containing both peptides at 5mg each
• Purity: 99% or higher — verified by independent lab testing (HPLC) for both components
• Lyophilised powder — stable and easy to store
• Consistent quality — every batch is tested before release

Why Choose RECHEMCO?

★ Experience you can trust. We have a long trading history in the research chemical market. When you order from us, you benefit from years of reliable service and supply chain expertise.

★ Tested and verified. Every batch of the Cagrilintide + Semaglutide stack is independently tested to confirm purity of 99% or higher for both peptides. You can request a Certificate of Analysis for your records.

★ Flexible payment options. We accept Bitcoin, major cryptocurrencies via Plisio, and credit card payments. Visit our payment methods page for full details.

★ Stable, long-term supply. Whether you need a single box or a recurring order, we maintain consistent stock levels to support your research.

Shipping and Delivery

• Processing time: Cagrilintide + Semaglutide is ready to be shipped within 72 hours after your payment is confirmed.
• Average delivery time: 2–3 weeks internationally, depending on your location and local customs processing.
• Discreet and secure packaging: We use damage-proof packaging and customs-conscious labelling to ensure your order arrives safely.

How to Store Cagrilintide + Semaglutide

Proper storage keeps your research material stable and effective:

• Lyophilised powder (unopened): Store in a freezer at -20°C. Keep away from light and moisture. Under these conditions, it can remain stable for up to 2 years.
• After reconstitution (mixed with liquid): Keep in a refrigerator at 2–8°C and use within 7 days. For longer storage, divide into single-use portions and freeze at -20°C. Avoid thawing and refreezing multiple times.

Always use sterile water or bacteriostatic water when reconstituting. Swirl gently — do not shake vigorously, as this can damage the peptides.

Safety Information for Researchers

The Cagrilintide + Semaglutide stack is supplied for research and forensic use only. It is not intended for human or veterinary use. However, understanding the safety profiles of both components from published studies helps researchers handle this combination responsibly and design better experiments.

Common effects observed in clinical studies of the combination:

• Nausea — the most frequently reported effect, typically mild to moderate
• Vomiting
• Diarrhoea
• Constipation
• Decreased appetite
• Stomach discomfort or indigestion
• Fatigue

These gastrointestinal effects are consistent with both GLP-1 receptor agonists and amylin analogues. They are usually most noticeable at the start of research and tend to decrease over time as the body adapts.

Less common but notable findings:

• Increased heart rate — a small rise has been observed, consistent with GLP-1 receptor activation
• Dizziness or light-headedness
• Potential for pancreatitis — rare, but documented with GLP-1 receptor agonists as a class
• Gallbladder problems, including gallstones — associated with rapid weight loss
• Thyroid C-cell tumours — observed in rodent studies with GLP-1 compounds; human relevance remains unclear
• Injection site reactions — possible with any peptide

Important considerations for combination research:

• Because this stack affects stomach emptying through two different pathways, researchers should be aware of the potential for compounded gastrointestinal effects.
• The combined appetite suppression may be significantly stronger than either peptide alone. Researchers should plan their protocols accordingly.
• Blood sugar monitoring is advisable in relevant research models, as both peptides influence glucose regulation.
• As with any research peptide combination, individual responses may vary.

Allergic reactions are possible but rare. Laboratories should maintain appropriate safety protocols and emergency procedures.

Responsible Research Practices

• Always wear gloves, a lab coat, and safety glasses when handling peptide powder or solutions.
• Work in a well-ventilated area or a fume hood.
• Keep detailed records of batch numbers, reconstitution dates, and storage conditions.
• Note the reconstitution ratio carefully, as this stack contains two peptides at equal 5mg concentrations.
• Dispose of any waste according to your institution’s chemical disposal guidelines.

Frequently Asked Questions (Simple Answers)

What is the Cagrilintide + Semaglutide stack used for in research? It is used to study dual-pathway appetite regulation, weight loss, metabolic health, and combination peptide therapy.

Why combine cagrilintide and semaglutide? They work through two completely different hormone pathways — GLP-1 and amylin. Targeting both at the same time produces a stronger, more complete effect on appetite and weight regulation.

How is this stack different from using semaglutide alone? Semaglutide alone only activates the GLP-1 pathway. Adding cagrilintide brings in the amylin pathway, creating a broader effect that leads to greater weight loss in studies.

What are the concentrations in each vial? Each vial contains 5mg of cagrilintide and 5mg of semaglutide.

How pure is RECHEMCO’s product? 99% or higher for each peptide component, verified by independent laboratory testing.

How should I store it? Freeze the powder. After mixing, keep it in the fridge and use quickly, or freeze in small portions.

Can I buy this stack for personal use? No. All products on this website are for research and forensic applications only. Not for human or veterinary use.

How long does shipping take? We ship within 72 hours of payment. Delivery usually takes 2–3 weeks.

Disclaimer

All products sold by RECHEMCO, including the Cagrilintide + Semaglutide stack, are intended strictly for research and forensic applications. They are not for human or veterinary use. The information provided here is based on published scientific studies and is meant for educational and research reference only. It does not replace professional medical advice, and it is not an instruction for human consumption. RECHEMCO is not responsible for any misuse of research chemicals.

Research carefully.